Heparin vs Warfarin and direct oral anticoagulants
How to tell Heparin and Warfarin and direct oral anticoagulants apart when a board question makes them look alike.
Heparin is immediate antithrombin/PTT; warfarin is vitamin K/PT-INR; direct oral agents are factor Xa or thrombin without routine INR.
Side by side
Rapid parenteral anticoagulation through antithrombin activation, classically monitored with PTT when unfractionated.
Oral anticoagulation: warfarin lowers vitamin K-dependent factors with INR monitoring, while direct oral agents inhibit factor Xa or thrombin without routine INR monitoring.
Heparin accelerates antithrombin inactivation of clotting factors, especially thrombin and factor Xa.
Warfarin blocks vitamin K recycling; direct oral anticoagulants directly inhibit factor Xa or thrombin.
PTT monitoring and protamine reversal point to unfractionated heparin.
PT/INR monitoring points warfarin; fixed-dose apixaban/rivaroxaban/dabigatran language points direct oral anticoagulants.
The trap
All three prevent thrombosis, but they target different cascade points with different monitoring and reversal. Heparin (immediate onset, IV or subcut, antithrombin activator, PTT monitoring, protamine sulfate reversal, HIT risk after 5 days) for inpatient acute treatment. Warfarin (oral, vitamin K epoxide reductase inhibitor blocks factors II/VII/IX/X plus protein C/S, PT/INR monitoring, vitamin K plus 4-factor PCC reversal, warfarin skin necrosis in first 48 hours from protein C drop) for long-term mechanical valves and valvular AFib; bridge with heparin for 5 days. Direct oral anticoagulants (apixaban and rivaroxaban target factor Xa; dabigatran targets thrombin; fixed dose, no routine monitoring; andexanet alfa reverses Xa inhibitors, idarucizumab reverses dabigatran) for non-valvular AFib and DVT/PE.
Watch it explained
The repair move
For anticoagulants, attach route, target, monitoring test, and reversal clue before choosing the drug.
Try a free question
CoreA hospitalized patient needs immediate anticoagulation and is started on an IV drug that activates antithrombin and is monitored with PTT. Which drug class best fits?
Show answer and explanation
Answer: A. Unfractionated heparin. Unfractionated heparin works rapidly through antithrombin and is classically monitored with PTT.
Why the other choices are tempting
- B. Warfarin inhibits vitamin K epoxide reductase and is monitored with PT/INR.
- C. Direct factor Xa inhibitors usually do not require routine coagulation monitoring.
- D. Aspirin is an antiplatelet drug, not an antithrombin-mediated anticoagulant.
- E. Ticagrelor blocks platelet P2Y12 receptors rather than coagulation factors.
Flashcards
Tap a card to flip it.
What is the fastest separator for Heparin vs Warfarin and direct oral anticoagulants?
Heparin is immediate antithrombin/PTT; warfarin is vitamin K/PT-INR; direct oral agents are factor Xa or thrombin without routine INR.
What clue should make you choose Heparin?
Rapid parenteral anticoagulation through antithrombin activation, classically monitored with PTT when unfractionated.
Quick answers
What is the fastest way to tell Heparin from Warfarin and direct oral anticoagulants?
Heparin is immediate antithrombin/PTT; warfarin is vitamin K/PT-INR; direct oral agents are factor Xa or thrombin without routine INR.
What is the key clue for Heparin?
Rapid parenteral anticoagulation through antithrombin activation, classically monitored with PTT when unfractionated.
What is the key clue for Warfarin and direct oral anticoagulants?
Oral anticoagulation: warfarin lowers vitamin K-dependent factors with INR monitoring, while direct oral agents inhibit factor Xa or thrombin without routine INR monitoring.
What is the common trap with Heparin vs Warfarin and direct oral anticoagulants?
All three prevent thrombosis, but they target different cascade points with different monitoring and reversal. Heparin (immediate onset, IV or subcut, antithrombin activator, PTT monitoring, protamine sulfate reversal, HIT risk after 5 days) for inpatient acute treatment. Warfarin (oral, vitamin K epoxide reductase inhibitor blocks factors II/VII/IX/X plus protein C/S, PT/INR monitoring, vitamin K plus 4-factor PCC reversal, warfarin skin necrosis in first 48 hours from protein C drop) for long-term mechanical valves and valvular AFib; bridge with heparin for 5 days. Direct oral anticoagulants (apixaban and rivaroxaban target factor Xa; dabigatran targets thrombin; fixed dose, no routine monitoring; andexanet alfa reverses Xa inhibitors, idarucizumab reverses dabigatran) for non-valvular AFib and DVT/PE.